Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,575.00

Mettler-Toledo International (NYSE:MTD) had its price target raised by Morgan Stanley from $1,450.00 to $1,575.00 in a research note released on Tuesday,Benzinga reports. They currently have an equal weight rating on the medical instruments supplier’s stock.

Several other brokerages also recently weighed in on MTD. Royal Bank Of Canada initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 price objective for the company. Rothschild & Co Redburn assumed coverage on shares of Mettler-Toledo International in a research report on Wednesday, September 2nd. They issued a “sell” rating and a $1,200.00 target price on the stock. Wells Fargo & Company increased their target price on shares of Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Stifel Nicolaus lifted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Monday, August 3rd. Finally, Jefferies Financial Group boosted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Five investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $1,469.15.

Mettler-Toledo International Trading Up 1.9%

NYSE:MTD opened at $1,640.13 on Tuesday. Mettler-Toledo International has a 1 year low of $1,023.05 and a 1 year high of $1,659.70. The stock has a market cap of $32.87 billion, a P/E ratio of 35.86, a P/E/G ratio of 3.24 and a beta of 1.19. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. The stock has a 50-day simple moving average of $1,438.56 and a 200-day simple moving average of $1,311.85.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping the consensus estimate of $10.78 by $0.68. The business had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%. The business’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the company earned $10.09 EPS. As a group, analysts anticipate that Mettler-Toledo International will post 47.37 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 240 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $1,427.14, for a total value of $342,513.60. Following the completion of the sale, the insider owned 259 shares in the company, valued at approximately $369,629.26. The trade was a 48.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Thomas P. Salice sold 417 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total value of $600,650.97. Following the completion of the sale, the director owned 292 shares of the company’s stock, valued at approximately $420,599.72. This represents a 58.82% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 4,254 shares of company stock worth $6,092,712. 0.71% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds have recently modified their holdings of MTD. V Square Quantitative Management LLC raised its position in Mettler-Toledo International by 3.4% in the 3rd quarter. V Square Quantitative Management LLC now owns 645 shares of the medical instruments supplier’s stock valued at $975,000 after purchasing an additional 21 shares during the last quarter. Assenagon Asset Management S.A. grew its position in Mettler-Toledo International by 48.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 49,900 shares of the medical instruments supplier’s stock worth $75,396,000 after purchasing an additional 16,292 shares during the last quarter. Baldwin Wealth Partners LLC MA purchased a new position in Mettler-Toledo International during the 3rd quarter worth $230,000. Wedmont Private Capital purchased a new position in Mettler-Toledo International during the 3rd quarter worth $457,000. Finally, GAMMA Investing LLC increased its stake in Mettler-Toledo International by 6.9% in the third quarter. GAMMA Investing LLC now owns 647 shares of the medical instruments supplier’s stock valued at $978,000 after purchasing an additional 42 shares during the period. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer of precision instruments and related services used in laboratory, industrial, food processing, pharmaceutical and retail applications. The company’s solutions help customers measure, analyze, inspect and control materials and products throughout research, manufacturing and distribution processes.

Its product portfolio includes laboratory balances and scales, analytical instruments, automated chemistry systems, titrators, density and refractometry equipment, process analytics, industrial weighing systems, product inspection technologies and retail weighing and labeling solutions.